CopyMark Law Group
4.9
Drawing for VUNWONY

USPTO serial 79355950

VUNWONY

Reviewed by CopyMark Law Group

Reg. 7191629Status 700Registered
Filing date
Status date
Registration date
Oct 17, 2023
Examiner
LADNER, CHRISOPHER G
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VUNWONY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell-based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 10, 2023GPNXNOTIFICATION PROCESSED BY IB—
Nov 17, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 17, 2023FIMPFINAL DISPOSITION PROCESSED—
Nov 16, 2023GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Oct 17, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 1, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 12, 2023NPUBNOTICE OF PUBLICATION—
Jun 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 22, 2023DOCKASSIGNED TO EXAMINER—
Dec 6, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 28, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 24, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance